Clinical Trial Update: Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a fluocinolone acetonide intravitreal implant versus sham injection in diabetic macular edema has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2014-05-07